do glp 1 cause anxiety Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Starting GLP-1s: What Users Wish

Yes and the science on this is encouraging

Further elaboration of our understanding of the initiating G-protein coupled receptor (GPCR) circuits engaged locally within the intestine and how they become altered with high-fat diet feeding can offer insight into the dysregulation observed in obesity and diabetes

Weight reduction Weight loss was similar between dulaglutide and exenatide twice daily but was greater with liraglutide compared to dulaglutide ( Figure 4 )

Ohki T, Isogawa A, Toda N, Tagawa K (2016) Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors

Learn How Compounded Semaglutide and Tirzepatide Programs Work for Women in Midlife Understanding the Menopause GLP-1 Weight Loss Connection: Why Women 40-64 Are Primary Users of These Medications Recent population-level data analysis from RAND American Life Panel reveals women aged 50-64 demonstrate the highest GLP-1 medication usage rates, with 20% reporting current or past use of these weight loss medications

Not a fan of eating the same meal on repeat